Dell Medical School, University of Texas, Department of Internal Medicine, Division of Dermatology, Austin, TX, United States.
Medical Dermatology Specialists; University of Arizona College of Medicine, Phoenix, AZ, United States.
Photodiagnosis Photodyn Ther. 2021 Sep;35:102358. doi: 10.1016/j.pdpdt.2021.102358. Epub 2021 May 29.
Data evaluating the effectiveness of photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% nanoemulsion gel and red-light LED lamp for the treatment of squamous cell carcinoma in situ (SCCis) on the trunk and extremities is limited. Our study sought to investigate the safety and efficacy of utilizing ALA 10% gel with red-light lamp for the treatment of SCCis on the trunk and extremities.
A single center prospective study of 12 patients with biopsy proven SCCis underwent one or two cycles of red-light PDT with ALA 10 % gel and 3 hours incubation period. Each cycle consisted of two treatments approximately 10 days apart. All participants had a biopsy for histologic evaluation 4 weeks following the last treatment.
All patients achieved clinical and histologic clearance following either one or two cycles at the 4-week post treatment follow up period. The majority of lesions were located on the extremities (n=10) with the remainder located on the trunk (n=2). The mean diameter of the lesions was 1.83 cm. Mild pain was noted in patients, with no interruption of treatment.
Our study indicates that ALA 10% gel with a red-light lamp is a safe and effective treatment option for SCCis on the trunk and extremities.
评估氨基酮戊酸(ALA)10%纳米乳凝胶和红光 LED 灯进行光动力疗法(PDT)治疗躯干和四肢原位鳞状细胞癌(SCCis)的有效性的数据有限。我们的研究旨在探讨利用 ALA 10%凝胶和红光灯治疗躯干和四肢 SCCis 的安全性和有效性。
对 12 例经活检证实的 SCCis 患者进行单中心前瞻性研究,接受了一次或两次红光 PDT 治疗,使用 ALA 10%凝胶并孵育 3 小时。每个周期大约相隔 10 天进行两次治疗。所有患者在最后一次治疗后 4 周进行活检进行组织学评估。
所有患者在治疗后 4 周的随访期内,经过一次或两次治疗均达到临床和组织学清除。大多数病变位于四肢(n=10),其余病变位于躯干(n=2)。病变的平均直径为 1.83cm。患者出现轻度疼痛,但未中断治疗。
我们的研究表明,ALA 10%凝胶和红光灯是治疗躯干和四肢 SCCis 的安全有效治疗选择。